Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $563,301 - $658,633
-7,554 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $276,416 - $313,286
3,747 Added 98.42%
7,554 $608,000
Q2 2021

Aug 12, 2021

BUY
$80.5 - $88.01 $306,463 - $335,054
3,807 New
3,807 $306,000
Q1 2021

May 12, 2021

SELL
$76.38 - $86.03 $729,658 - $821,844
-9,553 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $1.03 Million - $1.13 Million
-13,670 Reduced 58.86%
9,553 $767,000
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $694,630 - $804,593
8,868 Added 61.78%
23,223 $1.87 Million
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $611,030 - $731,279
7,768 Added 117.93%
14,355 $1.24 Million
Q1 2020

May 13, 2020

SELL
$71.57 - $93.3 $821,337 - $1.07 Million
-11,476 Reduced 63.53%
6,587 $535,000
Q4 2019

Feb 11, 2020

BUY
$76.7 - $88.45 $128,242 - $147,888
1,672 Added 10.2%
18,063 $1.51 Million
Q3 2019

Nov 12, 2019

SELL
$81.4 - $89.78 $563,939 - $621,995
-6,928 Reduced 29.71%
16,391 $1.43 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $169,499 - $190,202
-2,308 Reduced 9.01%
23,319 $1.91 Billion
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $290,611 - $366,464
-4,507 Reduced 14.96%
25,627 $0
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $120,065 - $132,019
1,698 Added 5.97%
30,134 $2.32 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $110,875 - $131,816
1,748 Added 6.55%
28,436 $2.1 Million
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $1.67 Million - $1.93 Million
26,688 New
26,688 $1.74 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Alphasimplex Group, LLC Portfolio

Follow Alphasimplex Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alphasimplex Group, LLC with notifications on news.